London Daily

Focus on the big picture.
Thursday, Sep 04, 2025

Booster Dose Protects Adults Above 65 Against Omicron Infections: UK Study

Booster Dose Protects Adults Above 65 Against Omicron Infections: UK Study

The UK Health Security Agency analysis showed that around three months after the third jab, protection against hospitalisation among those aged 65 and over remains at about 90 per cent.

A third top-up booster dose of a COVID-19 vaccine provides high levels of protection against severe disease from the Omicron variant among older adults, a latest UK study concluded on Saturday.

The UK Health Security Agency (UKHSA) analysis showed that around three months after the third jab, protection against hospitalisation among those aged 65 and over remains at about 90 per cent.

Whilst with a booster shot, the duration of protection against severe disease remains high, protection against mild symptomatic infection is more short-lived and drops to around 30 per cent by about three months.

The UKHSA study examined booster shots in those aged over 65, who were among the first to be eligible when the UK's booster vaccination rollout began in mid-September 2021.

The latest findings also show that protection from getting severe infection from the Omicron variant of COVID-19 after the first two doses wanes within months.

"With just two vaccine doses, protection against severe infection drops to around 70 per cent after three months and to 50 per cent after six months," the study noted.

The UK's Joint Committee on Vaccination and Immunisation (JCVI) said it has taken this latest evidence into account in its ongoing review of the booster programme and decided against the need for a fourth booster dose rollout at this stage.

"The current data shows the booster dose is continuing to provide high levels of protection against severe infections, even for the most vulnerable older age groups. For this reason, the committee has concluded there is no immediate need to introduce a second booster dose, though this will continue to be reviewed," said Professor Wei Shen Lim, the JCVI's chair of COVID-19 immunisation.

"The data is highly encouraging and emphasises the value of a booster jab. With Omicron continuing to spread widely, I encourage everyone to come forward for their booster dose, or if unvaccinated, for their first two doses, to increase their protection against serious illness," he said.

The JCVI has concluded that there is no immediate need to introduce a fourth jab to the most vulnerable groups such as care home residents and those aged over 80 and that priority should continue to be given to rolling out the first booster shots to all age groups.

However, extremely vulnerable patients with impaired immune systems are still advised to administer the fourth shot to get fully vaccinated.

More than 35 million boosters and third doses have now been administered across the UK, with the government's "Get Boosted Now" campaign at the end of last year to tackle the surge in coronavirus cases driven by the Omicron variant.

It comes at a time when the UK's daily infections rate continues to remain high, with another 178,250 cases being reported on Friday.

Hospitalisations, which have remained relatively low, have also started to rise among the vulnerable age groups.

As a result, the widespread staff absences due to self-isolation have caused severe pressures on the country's National Health Service (NHS), with Army personnel being drafted in for support in some regions.

"I think we have to be honest when we look at the NHS and say it will be a rocky few weeks ahead," said UK Health Secretary Sajid Javid.

About 4 per cent of hospital staff in England - nearly 36,000 - were off work for reasons related to COVID-19 during the week ending January 2. When other sickness absence is added, it brings the total to 9 per cent - nearly double what would normally be seen at this time of the year.

Comments

Oh ya 4 year ago
Well I guess the UK was not part of that study just released by 145 countries that basically says you vaxxed are going to die before the purebloods. People are leary of buy a new production model car but are OK with taking a jab with a drug that has never been tested correctly on humans using a delivery system MRNA that has never been used on humans yet killed all the test animals. Get your papers in order and best of luck because the top doctors in the world say there is no taking the deadly spike proteins out of your system

Newsletter

Related Articles

0:00
0:00
Close
Putin Celebrates ‘Unprecedentedly High’ Ties with China as Gazprom Seals Power of Siberia-2 Deal
China Unveils New Weapons in Grand Military Parade as Xi Hosts Putin and Kim
Queen Camilla’s Teenage Courage: Fended Off Attempted Assault on London Train, New Biography Reveals
Scottish Brothers Set Record in Historic Pacific Row
Rapper Cardi B Cleared of Liability in Los Angeles Civil Assault Trial
Google Avoids Break-Up in U.S. Antitrust Case as Stocks Rise
Couple celebrates 80th wedding anniversary at assisted living facility in Lancaster
Information Warfare in the Age of AI: How Language Models Become Targets and Tools
The White House on LinkedIn Has Changed Their Profile Picture to Donald Trump
"Insulted the Prophet Muhammad": Woman Burned Alive by Angry Mob in Niger State, Nigeria
Trump Responds to Death Rumors – Announces 'Missile City'
Court of Appeal Allows Asylum Seekers to Remain at Essex Hotel Amid Local Tax Boycott Threats
Germany in Turmoil: Ukrainian Teenage Girl Pushed to Death by Illegal Iraqi Migrant
United Krack down on human rights: Graham Linehan Arrested at Heathrow Over Three X Posts, Hospitalised, Released on Bail with Posting Ban
Asian and Middle Eastern Investors Avoid US Markets
Ray Dalio Warns of US Shift to Autocracy
Eurozone Inflation Rises to 2.1% in August
Russia and China Sign New Gas Pipeline Deal
China's Robotics Industry Fuels Export Surge
Suntory Chairman Resigns After Police Probe
Gold Price Hits New All-Time Record
Von der Leyen's Plane Hit by Suspected Russian GPS Interference in an Incident Believed to Be Caused by Russia or by Pro-Peace or by Anti-Corruption European Activists
UK Fintechs Explore Buying US Banks
Greece Suspends 5% of Schools as Birth Rate Drops
Apollo to Launch $5 Billion Sports Investment Vehicle
Bolsonaro Trial Nears Close Amid US-Brazil Tension
European Banks Push for Lower Cross-Border Barriers
Poland's Offshore Wind Sector Attracts Investors
Nvidia Reveals: Two Mystery Customers Account for About 40% of Revenue
Woody Allen: "I Would Be Happy to Direct Trump Again in a Film"
Pickles are the latest craze among Generation Z in the United States.
Deadline Day Delivers Record £125m Isak Move and Donnarumma to City
Nestlé Removes CEO Laurent Freixe Following Undisclosed Relationship with Subordinate
Giuliani Seriously Injured in Accident – Trump to Award Him the Presidential Medal of Freedom
EU is getting aggressive: Four AfD Candidates Die Unexpectedly Ahead of North Rhine-Westphalia Local Elections
Lula and Putin Hold Strategic BRICS Discussions Ahead of Trump–Putin Summit
WhatsApp is rolling out a feature that looks a lot like Telegram.
Investigations Reveal Rise in ‘Sex-for-Rent’ Listings Across Canada Exploiting Vulnerable Tenants
Chinese and Indian Leaders Pursue Amity Amid Global Shifts
European Union Plans for Ukraine Deployment
ECB Warns Against Inflation Complacency
Concerns Over North Cyprus Casino Development
Shipping Companies Look Beyond Chinese Finance
Rural Exodus Fueling European Wildfires
China Hosts Major Security Meeting
Chinese Police Successfully Recover Family's Savings from Livestream Purchases
Germany Marks a Decade Since Migrant Wave with Divisions, Success Stories, and Political Shifts
Liverpool Defeat Arsenal 1–0 with Szoboszlai Free-Kick to Stay Top of Premier League
Prince Harry and King Charles to Meet in First Reunion After 20 Months
Chinese Stock Market Rally Fueled by Domestic Investors
×